Myomo, Inc.

AMEX:MYO

Medical - Devices

Healthcare
$1.25 -8.80%

-$0.13 today

Market cap
$50.12M
Beta
1.46
P/E (TTM)
-3.6
EPS (TTM)
-$0.36
52W Low $0.61High $2.68

Volume 0.21M

Average 0.62M

MYO Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

Myomo, Inc.AMEX: MYO

Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026

Net change in cash declines year over year

Q1 FY2026 net change in cash of $2.74M (cash outflow) fell 40.3% year over year, ahead of the -157.0% change in trailing-twelve-month net change in cash. Over 3 fiscal years it compounded at -0.5% a year.

Context

  • Net change in cash amounted to 24.5% of revenue in FY2025, down 30.4 pp from a year earlier.
  • Net change in cash increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -40.3% holds above the trailing-twelve-month pace of -157.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$2.74M-273.3% QoQ
Last fiscal yearDec 2025
-$10.04M-156.2% YoY
LTMMar 2026
-$8.4M-157.0% YoY
Net Change in Cash past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-40.3%——
1 year-156.2%——
3-year CAGR-0.5%——
5-year CAGR——
10-year CAGR——

Net Change in Cash history

USD · from the cash flow

Latest · FY2025
(10.04M) USD
Year-over-year change
-156.2%

Net Change in Cash vs competitors

How MYO compares with its peers on the latest reported figures

  • MYO's LTM Mar 2026 net change in cash of $8.4M is the largest of the 4 companies compared; the peer median is $2.1M.
  • Its year-over-year change of -157.0% is the lowest of 4, against a peer median of +120.3%.
  • Net change in cash amounts to 20.4% of revenue for MYO, versus a peer median of 28.1%.
MYO Competitors Peer median
Net Change in Cash for MYO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MYOMyomo, Inc.LTM Mar 2026$8.4M -157.0%-0.5%20.4%
POCIPrecision Optics Corporation, Inc.LTM Mar 2026$8.13M +401.1%—28.1%
HYPDHyperion DeFi, Inc.LTM Jun 2026$2.1M -59.8%—150.3%
ECORelectroCore, Inc.LTM Mar 2026$825K +120.3%—2.4%
Peer median (excluding MYO) $2.1M+120.3%—28.1%

Competitors are the stored peer set for MYO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(10.37M)(10.72M)(8.15M)(6.18M)(15.57M)
Depreciation & Amortization335.96K542.63K517.68K776.97K1.98M
Deferred Income Tax00000
Stock-Based Compensation1.1M1.19M1.12M874.44K2.08M
Change in Working Capital(588.01K)(1.45M)293.21K1.26M(3.86M)
Accounts Receivables(1.05M)47.45K(495.6K)(1.56M)376.97K
Inventory(118.22K)(607.4K)(384.78K)(1.4M)(662.68K)
Accounts Payables1.11M(711.9K)1.79M4.69M(2.9M)
Other Working Capital576.49K(178.13K)(616.54K)(478.7K)(668.57K)
Other Non-Cash Items(19.73K)204.34K48.31K(17.37K)855.86K
Operating Cash Flow(9.55M)(10.23M)(6.17M)(3.29M)(14.51M)
Capital Expenditures(326.46K)(111.79K)(145.82K)(1.36M)(1.74M)
Acquisitions (Net)0(199K)000
Purchases of Investments0(199K)(5.88M)(5.98M)(5.47M)
Sales of Investments0398K4M7.6M1.74M
Other Investing Activities0(199K)00(1.59M)
Investing Cash Flow(326.46K)(310.79K)(2.03M)259.98K(7.06M)
Debt Repayment000011.43M
Common Stock Issued1.1M376.86K9.72M20.37M0
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities12.07M0(8.12K)563.64K0
Financing Cash Flow13.17M376.86K9.71M20.93M11.43M
Effect of Forex Changes(10.39K)(10.93K)14.21K(26.44K)101.7K
Net Change in Cash3.28M(10.18M)1.53M17.88M(10.04M)
Free Cash Flow(9.87M)(10.35M)(6.32M)(4.65M)(16.25M)

Myomo, Inc.

AMEX:MYO

Intrinsic Alpha fair value

Locked

Current Price

$1.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.